Drugs / GINSENG, AMERICAN
GINSENG, AMERICAN
also known as
American Ginseng · American Ginseng root · Panax Quinquefolius · AFX-02 · AFX-2 · American ginseng whole · Aralia quinquefolia · Aralia quinquefolia root · +17 more
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03407716 | Mar 2019 → May 2020 | breast carcinoma, colorectal carcinoma | Mayo Clinic | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT01456182 | Dec 2011 → Mar 2013 | B-cell chronic lymphocytic leukemia | Afexa Life Sciences Inc | Withdrawn | No outcome recorded |
| Phase 1 | NCT01136928 | Sep 2010 → Mar 2011 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 22 trials · 1 missed | ||||||
| Phase 2 | NCT00631852 | Feb 2008 → Jun 2019 | breast cancer | Southern Illinois University | Completed | No outcome recorded |
| Phase 2 | NCT00754832 | Sep 2005 → Sep 2008 | multiple sclerosis | Oregon Health and Science University | Completed | Missed primary |
| Phase 34 trials · 1 missed | ||||||
| Phase 3 | NCT06395441 | Aug 2024 → Dec 2027 expected | cancer | Mayo Clinic | Recruiting | No outcome recorded |
| Phase 3 | NCT00719563 | Oct 2008 → Aug 2011 | cancer of unknown primary site, leukemia, lymphoproliferative syndrome, myelodysplastic syndrome +4 | Alliance for Clinical Trials in Oncology | Completed | Missed primary |
| Phase 3 | NCT00367926 | Jun → Jul 2005 | hyperglycemia | Risk Factor Modification Centre | Completed | No outcome recorded |
| Phase 3 | NCT00219960 | Apr 2001 → Oct 2003 | hypertensive disorder | Risk Factor Modification Centre | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01500096 Comparator | Feb 2013 → Sep 2016 | AIDS-related disorder | Johns Hopkins University | Completed | No outcome recorded |
Evidence & citations 28 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GINSENG, AMERICAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | AFX-02 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | AFX-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01456182 ↗ |
| Known as | American Ginseng | “Dietary Supplement: American Ginseng” NCT06395441 ↗ |
| Known as | American Ginseng root | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00631852 ↗ |
| Known as | American ginseng whole | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Aralia quinquefolia | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Aralia quinquefolia root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Ginseng (panax quinquefolius) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Ginseng quinquefolium root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Ginseng, north american | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | HT-1001 | “Ginseng HT-1001 was dosed at 100 mg orally per day initially, increased after one week to 200 mg per day, then further increased the next week to 400 mg per day as tolerated.” NCT00754832 ↗ |
| Known as | NAG | “North American ginseng (NAG)” NCT00219960 ↗ |
| Known as | North American Ginseng | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00219960 ↗ |
| Known as | Panacis quinquefolii radix | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax americanus root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax cuneatus root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax quinquefolium root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax quinquefolium whole | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax Quinquefolius | “To evaluate the efficacy of American ginseng (Panax quinquefolius) as therapy for cancer-related fatigue as measured by the general subscale of the Multidimensional Fatigue...” NCT00719563 ↗1“North American Ginseng (Panax Quinquefolius)” NCT00219960 ↗ |
| Known as | Panax quinquefolius root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax quinquefolius root powder | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Panax quinquefolius whole | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Sang root | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Sang whole | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Known as | Xi yang shen | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109196 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The World Health Organization lists ginseng as a traditional medicine with very low toxicity.” NCT00631852 ↗ |
| Route | Oral | “Given orally” NCT00719563 ↗ |